Status:
COMPLETED
GlobalSurg 3: Quality and Outcomes in Global Cancer Surgery
Lead Sponsor:
University of Edinburgh
Conditions:
Breast Neoplasms
Gastric Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Aim The aim is to determine the variation in quality of cancer surgery worldwide. Quality will be determined using measures covering infrastructure, care processes, and outcomes. The study will concen...
Eligibility Criteria
Inclusion
- All consecutive patients undergoing therapeutic surgery (curative or palliative) for breast, gastric, and colorectal cancer should be included.
- Surgery is defined as a procedure requiring a skin incision performed under general or neuraxial (e.g. regional, epidural or spinal) anaesthesia.
- Both elective and emergency procedures should be included. Include patients in whom the pre-operative diagnosis was thought to be benign, but was subsequently found to be cancer, e.g. bowel obstruction found to be due to cancer during surgery.
- Include patients in whom the pre-operative diagnosis was thought to be cancer, but was subsequently found to be benign disease (ensure the "pathology" variable indicates not cancer; will not be included in primary analysis).
- Laparoscopic, laparoscopic-converted, robotic, and open cases should be included.
- Patients aged 18 years and over should be included .
- Surgery may be with curative or palliative intent. Include patients in whom curative surgery was attempted but abandoned, e.g. open/close laparotomy.
Exclusion
- Operations where breast, gastric, or colorectal cancer is not suspected to be the primary pathology should be excluded.
- Patients undergoing a procedure purely for diagnosis or staging should be excluded, e.g. open breast biopsy, staging laparoscopy.
- Patients undergoing a procedure which does not require a skin incision should be excluded, e.g. colonoscopy/endoscopy alone, chemo/radiotherapy alone.
- Patients presenting with recurrence of breast, colorectal or gastric cancer should be excluded.
Key Trial Info
Start Date :
April 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 23 2019
Estimated Enrollment :
15958 Patients enrolled
Trial Details
Trial ID
NCT03471494
Start Date
April 1 2018
End Date
April 23 2019
Last Update
June 7 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Edinburgh
Edinburgh, United Kingdom